U.S. Airlines Stock News

If you are wondering whether Skyworks Solutions is attractively priced or just a value trap, you are in the right place for a clear, valuation focused look at the stock. The share price last closed at US$59.78, with returns of 1.4% over the past 30 days, a 7.2% decline year to date, and a 6.2% decline over the last year that longer term holders will be very aware of. Recent coverage of Skyworks has centered on its role as a key semiconductor supplier and on how demand trends across...

If you are wondering whether OFG Bancorp at around US$41.39 is still good value or already pricing in a lot of optimism, you are asking the right question. The stock has had mixed recent returns, with a 1.2% decline over the last 7 days, an 11.4% gain over 30 days, 0.9% year to date, 2.4% over 1 year, 50.3% over 3 years and 134.3% over 5 years, which can change how investors think about both upside and risk. Recent news around OFG Bancorp has focused on its position as a US regional bank and...

If you are wondering whether Coty’s share price now reflects a fair deal or a value trap, you are not alone. This article focuses squarely on what the current valuation is really telling you. The stock recently closed at US$2.59, with returns of 3.2% over 7 days, a 22.9% decline over 30 days, a 16.7% decline year to date, and a 56.8% decline over 1 year, while the 3 year and 5 year returns stand at 76.9% and 67.9% declines respectively. Recent news around Coty has focused on its brand...

In February 2026, DexCom reported past fourth-quarter 2025 results showing sales of US$1,259.6 million and net income of US$267.3 million, alongside full-year 2025 sales of US$4.66 billion and net income of US$836.3 million. The company also reiterated its 2026 revenue guidance of US$5.16–US$5.25 billion and completed a US$500.0 million share buyback that reduced its share count by nearly 2%. We’ll now consider how DexCom’s reaffirmed 2026 revenue guidance and completed buyback program may...

Day One Biopharmaceuticals (DAWN) is back in focus after the company set February 24, 2026 as the date for its Q4 2025 earnings release and accompanying conference call. See our latest analysis for Day One Biopharmaceuticals. At a share price of $11.70, Day One Biopharmaceuticals has a 90 day share price return of 24.07% and a year to date share price return of 32.20%. The 1 year total shareholder return is 3.94% lower, which indicates that more recent momentum has picked up ahead of the...

Ategrity Specialty Insurance Company Holdings (ASIC) has drawn fresh attention after a sharp recent move in its share price, with the stock up 6.1% over the past day and 32.7% in the past week. See our latest analysis for Ategrity Specialty Insurance Company Holdings. The recent surge in Ategrity Specialty Insurance Company Holdings’ share price, including a 32.7% 7 day share price return and a 23.97% 90 day share price return, suggests short term momentum is building while year to date...

Berkshire Hathaway disclosed in the fourth quarter that it acquired a little more than five million shares of The New York Times Company, while separately New York Times Advertising and Magnite previously announced an expanded collaboration making Magnite's DV+ the preferred platform for private marketplace deals for the publisher’s mobile in‑app ad supply. The combination of a high‑profile shareholder like Berkshire Hathaway and a deeper in‑app advertising partnership highlights how New...

IDEXX Laboratories (NasdaqGS:IDXX) has announced that long-serving board member M. Anne Szostak will retire following the 2026 Annual Meeting of Stockholders. The company has recently appointed Michael G. Erickson, PhD, to its Board of Directors as part of an upcoming refresh in board composition. These board changes come as IDEXX trades at a share price of $623.13 and continues to adjust its governance structure. IDEXX Laboratories, trading on the NasdaqGS under the ticker IDXX, currently...

Hims & Hers Health (NYSE:HIMS) launched a compounded GLP-1 weight-loss medication and withdrew it shortly after following FDA scrutiny. Novo Nordisk has filed a patent infringement lawsuit against Hims & Hers related to compounded GLP-1 therapies. The company announced its largest-ever acquisition, Eucalyptus, as it pursues global expansion beyond weight-loss offerings. Hims & Hers Health focuses on telehealth-driven, direct-to-consumer treatments across areas like hair loss, mental health,...

If you are wondering whether IDACORP's current share price reflects its true value, this article will walk through what the numbers are actually saying about the stock. IDACORP recently closed at US$143.45, with returns of 8.5% over 30 days, 12.7% year to date, 29.0% over 1 year, 51.9% over 3 years and 88.9% over 5 years. These figures can influence how investors think about both its growth potential and risk profile. Recent coverage around IDACORP has focused on its position as a regulated...

Molson Coors Beverage (NYSE:TAP) has expanded its Topo Chico Hard Margarita lineup with new products. The release includes the brand’s first glass bottle format and a new Strawberry Hibiscus flavor. The launch adds to Molson Coors’ ready to enjoy alcoholic beverage portfolio, targeting premium and convenience focused demand. For investors watching NYSE:TAP, this launch comes as Molson Coors continues to build out its flavored alcoholic beverage offerings around a $49.47 share price. The...

Earlier in February 2026, Sportradar Group AG announced a multi-year agreement to supply its AI-powered GameFrame data and broadcast technology to NBC for the 2025–26 and 2026–27 NBA seasons across all NBC Sports regional networks in the United States. This deal not only extends Sportradar’s long-running relationship with NBC, it also showcases how the company’s live player-tracking and real-time analytics tools are becoming embedded in mainstream basketball broadcasts. We’ll now examine how...

Super Group (SGHC) (NYSE:SGHC) has drawn fresh attention after issuing 2026 guidance that calls for double digit revenue growth above US$2.55b, as well as higher targeted quarterly and annual cash dividends. See our latest analysis for Super Group (SGHC). That guidance lands after a volatile stretch, with a 7 day share price return of 8.48% helping to offset a 90 day share price decline of 17.06%. At the same time, the 1 year total shareholder return of 24.23% and 3 year total shareholder...

Scotts Miracle-Gro (SMG) has been drawing fresh attention after a recent stretch of mixed share performance, including a 1.2% one-day decline contrasted with gains over the past month and the past three months. See our latest analysis for Scotts Miracle-Gro. That 1.2% one day share price decline comes after a stronger stretch, with the 30 day share price return of 10.2% and 90 day share price return of 24.7% pointing to building momentum despite a mixed longer term picture, including a 1 year...

RingCentral (NYSE:RNG) has reported profitability and introduced its first quarterly dividend program. The company has expanded its AI efforts through a new partnership with OpenAI focused on enterprise-grade voice AI. RingCentral has also announced a larger share buyback authorization, signaling an increased focus on returning capital to shareholders. RingCentral, a provider of cloud-based business communications and collaboration tools, is moving through a significant transition as it...

If you are looking at Marathon Petroleum and wondering whether the current share price reflects its true worth, you are not alone. This article is built to help you frame that question clearly. The stock closed at US$192.82, with returns of 9.9% over 30 days, 16.8% year to date, 29.0% over 1 year, 62.5% over 3 years and a very large gain over 5 years of 289.2%, while the last 7 days saw a 5.1% decline that may have caught your eye. Recent attention on Marathon Petroleum has focused on its...

If you are wondering whether Booking Holdings at around US$3,870 a share still makes sense for your portfolio, or if the market is now mispricing it, this article will walk you through what the current valuation implies. The stock has recently pulled back, with a 6.5% decline over the last 7 days, a 24.1% decline over the last 30 days, a 27.3% decline year to date, and a 22.8% decline over the last year. Over longer periods, the 3 year and 5 year returns stand at 56.1% and 69.5%...

If you are looking at Elanco Animal Health and wondering whether the recent run has already priced in the opportunity, this article will help you frame what the current share price could mean for long term value. The stock finished the last session at US$24.75, with a 1.5% decline over the past week, a 1.4% gain over the past month, a 9.9% gain year to date, and a 122.8% gain over the past year. The 3 year return sits at 113.5% and the 5 year return at a 26.4% decline. These moves have come...

Powell Industries overview Powell Industries (POWL) has drawn investor attention after sizable share price moves, with the stock showing a negative 1 day return of 0.49% and a gain of 30% over the past month. See our latest analysis for Powell Industries. Despite a recent 7 day share price decline of around 7% from its latest close of US$544.15, Powell Industries still shows strong momentum when you look at its 30 day share price return of 30% and a very large 1 year total shareholder return...

This article explores whether Mirum Pharmaceuticals, at a share price of US$105.89, may still offer value or whether the current price already reflects a high level of optimism, by examining what the market valuation might be indicating. The stock has delivered returns of 2.7% over the last 7 days, 12.3% over 30 days, 35.6% year to date and 107.8% over 1 year, with a very large 3 year return and a 4.7x gain over 5 years that may have influenced how investors view its risk and reward...

Futu Holdings (NasdaqGM:FUTU) has drawn investor attention after recent share price weakness, with the stock showing declines over the past month and past 3 months despite a positive 1 year total return. See our latest analysis for Futu Holdings. The recent 1 day share price return of a 5.55% decline and 30 day share price return of a 9.22% decline suggest fading short term momentum, even though the 1 year total shareholder return of 33.07% keeps the longer term picture positive. If Futu’s...

Short term and long term return snapshot Southern Copper (SCCO) has drawn attention after a strong run across multiple timeframes, with the stock showing gains over the past day, week, month, past 3 months, year to date and past year. For context, the company’s reported total returns are 3.0% over the past day, 4.6% over the past week, 13.3% over the past month and 61.7% over the past 3 months, based on the latest data provided. Looking further out, Southern Copper’s total return figures...

Event context and recent share performance Peabody Energy (BTU) shares recently closed at $33.18, with returns over the past month, past 3 months, and year that may catch the eye of investors comparing coal producers in the broader energy sector. See our latest analysis for Peabody Energy. Peabody Energy’s 1 day and 7 day share price returns of 1.04% and 3.69% declines respectively extend a 30 day share price return of 12.59% decline, yet this sits against a 90 day share price return of...

Insulet, NasdaqGS:PODD, has approved a significant increase in its share buyback authorization. The company also extended the duration of its equity repurchase program, giving management more time to execute on the plan. The expanded authorization and longer timeline point to ongoing efforts to return capital to shareholders through repurchases. For investors watching NasdaqGS:PODD, the buyback update comes as the stock trades around $249.38. Recent performance has been mixed, with a 2.7%...